Glow sticks – Not just for parties anymore

University of Houston researcher using popular party favor to detect biothreats for US Navy

12-Jan-2024 - Remember that party where you were swinging glow sticks above your head or wearing them as necklaces? Fun times, right? Science times, too. Turns out those fun party favors are now being used by a University of Houston researcher to identify emerging biothreats for the United States Navy. It’s ...

Verici DX reaches a global licensing and commercialisation agreement with Thermo Fisher Scientific

Agreement grants rights to further develop an assay for pre-transplant prognostic testing

20-Nov-2023 - Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant, announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection. The exclusive ...

Beckman Coulter and Fujirebio enter into partnership

The goal is a patient-friendly, blood-based Alzheimer's disease test

22-Sep-2023 - Beckman Coulter Diagnostics and Fujirebio announced a new partnership combining their respective immunoassay strengths to support therapeutic development, clinical trials, reimbursement, and routine clinical adoption in the field of neurodegenerative diseases. The burden of disability and deaths ...

'Mysterious' non-protein-coding RNAs play important roles in gene expression

16-Jan-2017 - In cells, DNA is transcribed into RNAs that provide the molecular recipe for cells to make proteins. Most of the genome is transcribed into RNA, but only a small proportion of RNAs are actually from the protein-coding regions of the genome. "Why are the non-coding regions transcribed at all? ...

Stay out, stray stem cells

18-Aug-2016 - Despite the hubbub about pluripotent stem cells’ potential applications, when it comes time to introduce products into patients, the stem cells are actually impurities that need to be removed. That’s because this type of stem cell is capable of becoming teratomas – tumors — when transplanted. For ...

Zika virus test receives FDA emergency use authorization

Test provides same day results and the option to test urine alongside blood

22-Jul-2016 - Viracor-IBT Laboratories Inc. (Viracor-IBT), a wholly-owned subsidiary of Eurofins Scientific (EUFI.PA), announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay. Viracor-IBT will perform this assay ...

Thermo Fisher Scientific and Immundiagnostik Collaborate To Develop Mass Spectrometry-Based Clinical and Research Tools

18-Oct-2012 - Thermo Fisher Scientific, Inc. and Immundiagnostik AG announced a collaboration to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides. The goal is development of commercial assays to be widely applicable in research and routine clinical ...

Agilent Technologies Secures Patent for CGH Assays

21-Aug-2012 - Agilent Technologies Inc. announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic and clinical research. The U.S. patent (No. 8,232,055) has claims for measuring copy number changes in ...

ACEA Biosciences, Inc. Announces New Patent

Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing

18-Feb-2011 - ACEA Biosciences, Inc. reported the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products. Testing and profiling of these candidate compounds by means of ACEA's real-time, label-free microelectronic technology ...

Thermo Fisher Scientific Collaborates on Clinical Biomarker Research with Leading Proteomics Researcher in Luxembourg

26-Apr-2010 - Thermo Fisher Scientific Inc. and Professor Bruno Domon, director of the new Luxembourg Clinical Proteomics unit (LCP), announced a collaboration to develop workflows that overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research. The LCP is funded ...